Send me real-time posts from this site at my email

What's in the Cards for Fuel Tech (FTEK) in Q1 Earnings?

Fuel Tech, Inc. FTEK is scheduled to report first-quarter 2019 results on May 13, after market close.

The company reported better-than-expected earnings results in the fourth quarter of 2018, wherein its earnings of 4 cents beat the Zacks Consensus Estimate of breakeven.

In the past three months, the company’s share price increased 114.8%, outperforming the industry’s increase of 13.8%.

Let us see how things are shaping up for Fuel Tech this quarter.

Factors Influencing Fuel Tech’s Performance

We believe that providers of pollution control equipment and services are currently realizing benefits of strict government regulations, pollution-related risks, growing demand in emerging nations and increasing awareness among public. For instance, the company continues to market its technologies successfully in many European countries, in the wake of the European Union's Industrial Emissions Directive in BREF. These positives are likely to be reflected in the company’s upcoming financial results.

Also, Fuel Tech’s results can be influenced by a number of company-specific matters. Notably, increased adoption and growing requirement for the company’s advanced proprietary solutions in energy industry are likely to have stoked growth in the first quarter. Also, investments in the water and wastewater treatment market will be conducive to its top line.

The company’s FUEL CHEM segment’s results might be influenced by efforts to improve sales channel, building strong customer relationship, and the addition of a new coal-fired unit at an existing customer in the United States. As a matter of fact, strong demand for advanced emission control technologies from coal-fired power generation customers across the globe will prove conducive to top-line growth in the first quarter.

Also, Air Pollution Control segment will benefit from a strong pipeline of contract opportunities on a global basis and efforts on product developments.

However, rising cost of sales and operating expenses are major concerns for the company. We believe that unwarranted rise in costs and expenses might be detrimental to its first-quarter performance.

Earnings Whispers

Our proven model provides some idea about the stocks that are about to release earnings results. Per the model, a stock needs a combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for a likely earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

The case with Fuel Tech has been provided below.

Earnings ESP: Fuel Tech has an Earnings ESP of 0.00% as both the Zacks Consensus Estimate and Most Accurate Estimate for the quarter are pegged at breakeven.

Fuel Tech, Inc. Price and EPS Surprise

Fuel Tech, Inc. Price and EPS Surprise | Fuel Tech, Inc. Quote

Zacks Rank: The company currently sports a Zacks Rank #1.

Note that we caution against stocks with a Zacks Rank #4 or 5 (Sell-rated) going into the earnings announcement, especially when the company is seeing a negative estimate revisions momentum.

Stocks to Consider

Here are some companies that you may want to consider as these have the right combination of elements to post an earnings beat this quarter, according to our model.

Chaparral Energy, Inc. CHAP presently has an Earnings ESP of +110.00% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.

Commercial Metals Company CMC has an Earnings ESP of +1.40% and a Zacks Rank #3.

Axsome Therapeutics, Inc. AXSM currently has an Earnings ESP of +12.90% and a Zacks Rank #3.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Axsome Therapeutics, Inc. (AXSM): Free Stock Analysis Report
 
Fuel Tech, Inc. (FTEK): Free Stock Analysis Report
 
Commercial Metals Company (CMC): Free Stock Analysis Report
 
Chaparral Energy, Inc. (CHAP): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

Welcome!!! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue